Ljubljana, Slovenia - Bio-ReCell is proud to announce its strategic collaboration with BIOTEM, integrating BIOTEM’s advanced humanized antibodies into Bio-ReCell’s Atract™ T-cell activation kit and Neptune™ T-cell separation kit. This partnership is set to enhance precision, efficiency, and scalability across cell therapy manufacturing processes, supporting the industry’s growing demand for reliable and innovative solutions.
BIOTEM provides high added value services for the development / production of custom monoclonal antibodies and immunoassays. Their expertise in antibody development perfectly complements Bio-ReCell’s mission to deliver biocompatible, scalable, and sterile solutions for cell therapy manufacturing. By incorporating BIOTEM’s antibodies, Bio-ReCell’s products will offer increased reproducibility and superior performance, addressing critical challenges in the cell and gene therapy space.
Dr. Luka Fajs, CEO of Bio-ReCell, commented:
“We deeply value our partnership with BIOTEM, as their humanized antibodies are essential to improving our cell activation and separation products. This collaboration helps us deliver high-performance solutions with consistent quality and reliability.”
Dr. Clarence DEFFAUD, CEO/CSO of BIOTEM, commented:
“We are delighted and honored to collaborate with Bio-ReCell and bring our expertise in antibody engineering for the development of an innovatve tool. The partnership between our two companies has produced excellent results.”
About Bio-ReCell
Founded in 2018 and based in Ljubljana, Slovenia, Bio-ReCell specializes in cell separation and activation technologies, with a focus on scalable and biocompatible solutions for the cell therapy industry. Its proprietary antibody-based approach eliminates the need for magnetic particles, ensuring optimal sterility and scalability in T-cell processing. By continuously driving innovations in cell and gene therapy manufacturing, Bio-ReCell develops products that meet the highest standards of quality and reproducibility.
For more information visit: www.bio-recell.com
About BIOTEM
Expert in immunotechnology since 1980, BIOTEM is a Contract Research Organization which provides high added value services for the development/engineering of custom monoclonal antibodies and immunoassays (ELISA & LFIA). Complying with ISO 9001:2015 / ISO 13485:2016 Quality Standards, the company has been the privileged partner of more than 500 prestigious industrial and academic laboratories for their projects in fundamental research, development of improved diagnostics or generation of promising therapeutic tools.
Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project according to the client’s specifications. As a benefit, BIOTEM is keen to propose contracts with guaranteed results.
For more information visit: www.biotem-antibody.com